1. Home
  2. LOVE vs FULC Comparison

LOVE vs FULC Comparison

Compare LOVE & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Lovesac Company

LOVE

The Lovesac Company

HOLD

Current Price

$14.36

Market Cap

249.4M

ML Signal

HOLD

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$3.71

Market Cap

285.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOVE
FULC
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
249.4M
285.4M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
LOVE
FULC
Price
$14.36
$3.71
Analyst Decision
Strong Buy
Hold
Analyst Count
6
5
Target Price
★ $23.17
$3.67
AVG Volume (30 Days)
198.0K
★ 1.3M
Earning Date
09-10-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $697,115,000.00
N/A
Revenue This Year
$0.13
N/A
Revenue Next Year
$7.96
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 2.42
N/A
52 Week Low
$10.33
$2.83
52 Week High
$19.25
$15.74

Technical Indicators

Market Signals
Indicator
LOVE
FULC
Relative Strength Index (RSI) 44.98 46.26
Support Level $13.43 $3.62
Resistance Level $16.13 $3.91
Average True Range (ATR) 0.58 0.06
MACD 0.03 -0.00
Stochastic Oscillator 19.43 44.83

Price Performance

Historical Comparison
LOVE
FULC

About LOVE The Lovesac Company

The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

Share on Social Networks: